Vitavir® 90 mg
The International Nonproprietory Name: Vitavirin
Indications for use:
In preclinical and clinical studies, Vitavir (pentanedioic acid imidazolylethanamide) has shown efficacy against influenza viruses of type A (A(H1N1), including "porcine" A(H1N1)pdm09, A(H3N2), A(H5N1) and type B, adenovirus, parainfluenza virus, respiratory syncytial virus; in preclinical studies: coronavirus, metapneumovirus, enteroviruses, including Coxsackie virus and rhinovirus.
In preclinical and clinical studies, Vitavir (pentanedioic acid imidazolylethanamide) has shown efficacy against influenza viruses of type A (A(H1N1), including "porcine" A(H1N1)pdm09, A(H3N2), A(H5N1) and type B, adenovirus, parainfluenza virus, respiratory syncytial virus; in preclinical studies: coronavirus, metapneumovirus, enteroviruses, including Coxsackie virus and rhinovirus.
Dosage
and packing
and packing
90 mg № 7
Form of vacation
Without a prescription
Release form
Powder for the preparation of a solution for oral administration
Pharmacotherapeutic
group
group
Antiviral
Anatomical-therapeutic-chemical classification
Direct-acting antiviral drugs
© Belpharm. All Rights Reserved.
Developed in manufact.pro
Developed in manufact.pro